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Background: Introduction of human papillomavirus (HPV) vaccine in national programs has proceeded apace since
2006, mostly in high-income countries. Recently concluded pilots of HPV vaccination in low-income countries have
provided important lessons learned for these settings; however, rigorous evaluations of the feasibility of these delivery
strategies that effectively reach young adolescents have been few. This paper presents results from a qualitative
evaluation of a demonstration program which implemented school-based and health center–based HPV vaccinations
to all girls in grade 6, or 11 years of age, for two years in four districts of Vietnam.
Methods: Using semi-structured interviews of 131 health and education staff from local, district, province, and national
levels and 26 focus-group discussions with local project implementers (n = 153), we conducted a qualitative two-year
evaluation to measure the impact of HPV vaccinations on the health and education systems.
Results: HPV vaccine delivery at schools or health centers was made feasible by: a. close collaboration between the
health and education sectors, b. detailed planning for implementation, c. clearly defined roles and responsibilities for
project implementers, d. effective management and supervision of vaccinations during delivery, and e. engagement
with community organizations for support. Both the health and education systems were temporarily challenged with
the extra workload, but the disruptions were short-lived (a few days for each of three doses) and perceived as worth
the longer-term benefit of cervical cancer prevention.
Conclusion: The learning from Vietnam has identified critical elements for successful vaccine delivery that can provide
a model for other countries to consider during their planning of national rollout of HPV vaccine.
Keywords: HPV vaccine, Feasibility, Health system, School-based, Vaccine delivery, VietnamBackground
Safe and effective human papillomavirus (HPV) vaccines
provide a new opportunity for cervical cancer primary
prevention [1,2]. National introduction of HPV vaccine
has proceeded apace since 2006, with vaccinations to
occur in 54 national programs by the middle of 2013
[3,4]. Initial introduction from 2006 to 2008 was largely
contained in high-income countries, such as Australia,* Correspondence: slamontagne@path.org
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distribution, and reproduction in any mediumthe United States, and Europe, where the rates of
cervical cancer are lowest [4,5]. Since 2008, a handful of
middle-income countries, such as Mexico and Panama,
have phased in HPV vaccine with purchases at discounted
prices through the Pan-American Health Organization
(PAHO) Revolving Fund [6]. Rwanda became one of the
first low-income countries to introduce HPV vaccine na-
tionally in 2011, representing a new phase in the global
adoption of this life-saving intervention [7].
Much of the post-introduction literature has come
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of vaccination on disease endpoints [8-15]. However,
there is a dearth of literature evaluating the mechanics
of delivery and feasibility of the health system to incorp-
orate HPV vaccine [16,17]. Experiences from implemen-
tation in high-income countries may not necessarily be
relevant or translatable to low-income countries, which
have the most to gain from adoption of HPV vaccine,
given that more than 88 percent of all deaths from cer-
vical cancer occur in these countries [18].
On a small scale, some evidence of the feasibility of
HPV vaccine delivery in developing countries is emer-
ging from the evaluation of pilot projects or demonstra-
tion programs, which have provided insight into both
the challenges of implementation and the components
of the programs that have been successful [7,19,20]. A
large demonstration program of school-based HPV vac-
cine delivery in Peru found that close coordination with
the schools was key for successful delivery [19], and the
national introduction of HPV vaccine in Rwanda noted
the strong political support from the national to the
community level as being critical to vaccine uptake [7].
Conversely, a review of eight pilots done through small
donations of HPV vaccine suggested that insufficient
training and sensitization of teachers and school headmas-
ters, lack of community participation, and loss-to-follow-
up can be significant barriers for feasible programs [20].
Examples of HPV vaccine implementation within the
routine immunization systems of Asian countries are
largely absent. Formative research, prior to vaccine avail-
ability, from India and Vietnam, explored the types of
models for HPV vaccine delivery that communities
would accept and that governments would find feasible
[21-24]. These studies found a strong immunization de-
livery system in place, as well as communities and pol-
icymakers receptive to the idea of a vaccine to prevent
cervical cancer [22-24]. The government of Vietnam uti-
lized the results from this formative research to design
and implement a two-year demonstration project to test
whether a school-based or health center–based delivery
of HPV vaccine would result in higher coverage, achieve
strong community acceptance, and be feasible within the
existing health system [25]. This project was imple-
mented in 72 communes of four districts in Thanh Hoa
province (rural, in the north) and Can Tho city (urban,
in the south) in Vietnam by the National Expanded
Program on Immunization (NEPI) under the auspices
of the National Institute of Hygiene and Epidemiology
(NIHE) and in collaboration with the National Center
for Health Education and Communication (NCHEC)
and PATH [26]. All girls in grade 6 regardless of age
(school-based) or 11 years of age (health center–based)
were targeted, with vaccinations occurring a day before
or a day after the regularly scheduled monthly date forroutine immunizations of infants. Delivery was pulsed:
one day allocated for delivery of each of three doses of
HPV vaccine [25], using the standard schedule of 0, 2,
6 months.
The HPV vaccine demonstration project implemented
in Vietnam in 2009 and 2010 was evaluated for coverage
achieved by the strategies, community acceptability, sys-
tem feasibility, and incremental economic and financial
costs of delivery. Project details and results for coverage
achieved, acceptability by parents, and costs of imple-
mentation have been published elsewhere [25-27]. How-
ever, to briefly summarize, coverage in the first year was
83% in school-based delivery and 94% for health-center
based delivery, and for year two coverage was 96% and
99%, respectively [25]. The reasons for the lower cover-
age in the first year for school-based delivery was sys-
tematically evaluated and related to acceptability, with
rumors on safety influencing parental decisions in one
urban district only [25,26]. Coverage in the other three
project districts in the first year that delivered vaccine
via schools was similar to that achieved through the
health center-based approach. Using reporting guidelines
for qualitative studies (RATS), this paper presents the
findings from a two-year qualitative evaluation of the
feasibility of HPV vaccine delivery to determine the im-
pact of incorporating HPV vaccine on the health and
education systems in Vietnam.
Methods
Study design and objective
We designed a descriptive qualitative study to determine
the impact of incorporating HPV vaccine on the five
levels of the health and education system in Vietnam:
national, regional, provincial, district, and commune.
Study population, sampling frame, and sample size
We employed criteria-based purposive sampling to se-
lect 24 communes for study inclusion. All 72 communes
participating in the demonstration program were divided
based on HPV vaccine-delivery strategy (school-based or
health center–based), geographic stratum (mountainous,
rural, and urban), and first dose HPV vaccine uptake rate
(low versus high). After categorization, 12 communes
were randomly selected in each year and represented both
delivery strategies (6 school-based and 6 health-center
programs), all three geographic strata (4 urban, 4 rural,
4 mountainous), and high and low uptake (6 high and
low). All 72 communes were randomized in each year
so any individual commune had a chance to be selected
into both the year 1 and year 2 samples: 3 of the final
24 selected communes participated in the study in both
years. Within each commune, specific populations were
purposively selected based on their involvement with de-
livering HPV vaccinations. These included health workers,
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stakeholders. In the Vietnamese context, each commune
has one health center and usually one school, so partici-
pants in the HPV vaccine delivery program were known
and invited to voluntarily participate by the research team.
Both communes and individual study populations within
communes were selected to provide breadth of program-
matic experience, a technique common for qualitative re-
search [28,29], and not for sample representativeness, as is
done in a quantitative study.
After the first round of vaccinations was complete, 112
semi-structured interviews (SSIs) with NEPI and NCHEC
national and regional leaders, government leaders, health
and education staff at provincial, district and commune
levels were completed; after the second year of implemen-
tation, 26 focus group discussions (FGDs) with 153 project
implementers and an additional 19 semi-structured inter-
views with national, regional, and provincial leaders in the
health system were conducted (Table 1). We utilized SSIs
in year 1, as it was not yet known how comfortable pro-
gram implementers would be in discussing operational as-
pects that may be considered sensitive. However, results
from year 1 illustrated high levels of collaboration between
program implementers, reflecting the trusting working re-
lationship; thus, in year 2, FGDs were utilized for primary
data collection.
Data collection and analysis
All interviews and FGDs were conducted by trained
researchersa and based on a question guide, covering
areas of inquiry relevant to the objective of the feasibility
evaluation and covered major operational areas of vac-
cine delivery systems required for all vaccines, includ-
ing HPV [17,19,20,22,25]. To assess the impact on the
health system, questions related to human resources,
workload, system constraints, vaccine storage, trans-
port, and cold chain were asked. Questions specific toTable 1 Study populations, sample size, and data collection

























SSI 104 n/a 10 114
FGD n/a 26 153 153
Total 112 172 284
Abbreviations: FGD Focus Group Discussion, SSI Semi-structured Interview.the school setting—such as preparations, involvement
of school staff, disruptions, and coordination with the
health sector—were asked to reflect the impact on the
education system. An overarching theme of collaboration
between sectors and across the four principal levels of the
Vietnamese health system (commune, district, provincial,
and national) was probed through an additional series of
questions. For all respondents, other areas of inquiry
included: health-facility services, personnel, and work-
ing hours; adequacy of preparations for community
sensitization and mobilization; process of enumerating
vaccine-eligible girls prior to vaccination and efforts taken
to reach girls not in school; and activities that should or
should not be replicated for future vaccinations—i.e., what
worked well and what worked less well.
All conversations were tape-recorded and written in re-
searchers’ field notes. Interviews and FGDs took place in a
setting conducive to ensuring privacy, most often at either
health centers or schools nearby health centers. We cre-
ated a qualitative data repository system, including an elec-
tronic database, to facilitate organization, security, quality
control, maintenance, and analysis of study data. All data
were cleaned, coded, and de-identified prior to analysis.
Field notes were entered into Atlas.ti software (ATLAS.ti
Scientific Software Development, Berlin, Germany) for data
management, after verification of accuracy with tape re-
cordings of interviews and FGDs. All qualitative data
from SSIs and FGDs were then transferred into NVivo
software (QSR International, Burlington, MA, USA) for
analysis using a qualitative, thematic approach [28],
which involved sorting, categorizing, and summarizing
data to answer questions framed by each key area of
inquiry (outlined above). All results from SSIs and FGDs
were grouped according to three major themes – impact
on the health system, impact on the education system,
and intersectoral collaboration. Direct quotes from study
participants are presented in the results section as repre-
sentations of the most salient and prevalent themes and
subthemes identified from all interviews and FGDs—a
data presentation technique common in qualitative re-
search [29]. All data were collected and analyzed in
Vietnamese. However, for quality control and data
reporting, English translations and back translations of
thematic analyses, especially for the quotes were con-
ducted by two co-authors (NQN and LTN). Two co-
authors who are native English speakers (DSL and AJ)
verified the English translation of the thematic analyses.
Ethics
Verbal consent was solicited from all study participants
using a pre-defined script. A member of the research
team involved in either the interview or FGD noted by
signature on the data recording form that verbal consent
was received. All respondents were given a small thank-
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ation, per Vietnamese custom. The research protocol was
approved by the internal review board of NIHE (Vietnam)
and the research ethics committee of PATH (USA).
Results
Impact of HPV vaccinations on the health system
HPV vaccine introduction impacted personnel and the
regular activities of commune health centers in several
ways. Shortage of personnel on vaccination day was men-
tioned after both rounds of vaccinations. To deal with this
problem, many commune health centers mobilized add-
itional personnel from commune-level mass organizations
or health staff from districts and provinces.
We usually mobilized staff from reproductive health
units, disease control units, or food safety and security
units for not only HPV vaccination but also for monthly
EPI [Expanded Program on Immunization] activities
at all 13 communes from the first to the fifth. We did
not have adequate staff.
SSI, District health staff, School-based strategy, Can
Tho city, urban
The first sessions of HPV vaccination needed the sup-
port from the People’s Committees, educational sector,
and civic organizations such as the Women’s Union.
Health officials took the lead in garnering support from
these organizations, while also being responsible for
conducting vaccinations. During the first round of vacci-
nations delivery of HPV vaccine with existing health
worker staff created extra work. However, this was re-
duced in the second round, with only one mountainous
commune particularly affected.
As we have few health workers, the arrangement of
one-way flow with many tables for vaccination [4
stations: screening, counseling, vaccinating,
recording], sessions are sometimes difficult for us. Due
to the lack of staff, we also have more difficulties in
doing both communication and vaccination activities
than in other places.
FGD, Health workers in Nam Xuan and Hien Kiet
communes, Quan Hoa district, Thanh Hoa province,
mountainous
Health staff emphasized that introduction of a new
vaccine required greater investment in communication
activities and training to deliver the first dose, leading to
significant changes in their workload, which decreased
for the second and third doses. Additionally, during vac-
cination sessions, standard procedures and the process ofimmunization were followed according to project guide-
lines, which required more staff for screening and coun-
seling girls in comparison to other immunization days (for
children and infants). The project also required more
supervision, which placed a greater burden of work on
health staff in provinces and districts.
Communicators at villages were involved in
communication. District reproductive health staff also
supported us in training communicators. During
vaccination days, we ourselves divided into small
teams to go to communes. As this vaccine is new,
communication to parents was conducted in the
school, but several people still did not understand
well. Thus, we must visit families to explain more.
SSI, District health staff, Health center–based strategy,
Can Tho city, urban
Though faced with a heavy workload, health workers
acknowledged that the situation was under control and
workable. To accomplish the task with their limited re-
sources, they developed a reasonable working calendar.
They also showed commitment to the work, given the
benefits of the vaccine for the community.
We should save time for this activity. Although
sometimes it overlapped our work and schedule and
caused difficulty for us, with our determination,
endeavor, and enthusiasm, along with direction from
higher level, we tried to complete the task.
FGD, Health worker in Hung Loi and An Cu
communes, Ninh Kieu district, Can Tho city, urban
Sentiments from commune and district-level health
workers were reinforced by interview data from govern-
ment and health leaders. Most leaders confirmed that
“staff were working at their maximum capacity.” Leaders
from both government and the health sector also men-
tioned that district and commune staff were able to arrange
to have enough staff for the vaccination sessions. There
was no need to recruit new staff for HPV vaccination.
Identifying girls eligible for HPV vaccination was
noted by health workers as a task that was time-
consuming and contributed to the heavy workload. Mak-
ing a list of eligible girls for HPV vaccinations is consid-
ered a critical activity in the HPV vaccination program
that requires precise supervision, as this list is used for
vaccine and other equipment supplies. In the communes
that used school-based delivery, the list was first taken
from schools and reviewed by commune health staff. In
communes with health center–based delivery, the list
was obtained from the village first and then compared
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the burden of this task between the two strategies, since
the list was collected from two sources, in either case,
and checked by health staff for the final version.
On the whole, however, most study participants from
district and commune levels, regardless of delivery strat-
egy utilized, reported that routine health services were
not negatively impacted by HPV vaccine delivery. After
the first round of vaccinations, 61.8 percent of health
workers and 78.3 percent of community leaders who
were interviewed reported that HPV vaccination did not
affect routine health services or activities. They attributed
this to health workers being familiar with immunization
activities, enabling them to prioritize their time and
work during HPV vaccination days, the extra assistance
from non-health personnel (leaders, teachers, etc.), and
the benefit of vaccination sessions not lasting too long
(taking up one morning for administration of each
dose). Immunization program staff at the provincial
level responded similarly.
The densely populated district in the south that partic-
ipated in the HPV vaccine demonstration project did,
however, report negative impacts of HPV vaccine intro-
duction on regular activities of the commune health cen-
ter, such as reduced services for health checks and
treatment during the vaccination session. They reported
that more time and energy of health staff were put into
preparation activities, including training, planning meet-
ings, listing eligible girls, and organizing communication
activities, and these activities affected their other health
activities.
In both provinces, HPV vaccines were transported
along administrative levels from province to district by
specialized car and/or cold boxes and from district to
commune by motorcycle and vaccine carriers. Health
workers did not report any difficulty in the transport
and storage procedures of HPV vaccines in the program,
which followed guidelines from the Ministry of Health.
At the provincial level, the cold chain was equipped with
sufficient capacity in terms of storing and transporting
vaccine to lower levels.
Most participants said that vaccine had been trans-
ported and stored following the current effective regula-
tions and under close supervision. There were no
complaints about cold chain capacity for vaccine storage
or that the addition of HPV vaccines affected the storage
and cold chain of the other routine vaccines in the par-
ticipating districts.
No effect. We have three cold boxes, then there is no
problem if we integrate [HPV vaccination] into routine
immunization… Every month we have only about 30
children for routine vaccination. For HPV vaccine it
depends on age groups.SSI, Leader of District Health Center, Thanh Hoa
province, rural
Impact of HPV vaccination program on the education
system
The involvement of schools was more intensive in the
school-based strategy due to vaccinations occurring
while girls were in school. From the education system
perspective, the most frequently cited effects included
impacts on the learning activities of students, school ac-
tivities, and the volume of work for teachers. Some
schools arranged vaccination days during the school day
when all girls in grade 6 were allowed to leave class for
about 45-50 minutes to get vaccinated in a separate room
which was set-up for this purpose. Some schools orga-
nized vaccination days after school hours, but vaccinations
were still conducted on the school premises. Most schools
had more than one class of girls in grade 6, so multiple
vaccinations sessions were run on the day of vaccination.
Learning activities of pupils were the most influenced
when vaccination was organized during workdays, re-
gardless of the strategy. In general, pupils needed about
45 minutes to complete the vaccination process.
First, as this vaccination should be completed in the
morning, we decided to organize immunization
sessions in the morning. Thus, all children left class
whenever health workers came. After injection,
children could not continue to study, so we decided to
close the class at that time. Children who had missed
lessons should come in the afternoon next day. Thus, it
is only [a]delay of [the] school day, [and] school week,
but not [a] delay of [the]yearly program. So, besides
working in that morning (immunization session),
teachers must work one more afternoon.
SSI, Vice Headmaster, School-based strategy, Thanh
Hoa province, rural
The impact on learning and teaching activities depended
on school coordination capacity. Many schools had very
good coordination, inviting students from the same class
to a waiting room, then taking them to a vaccination room
individually to minimize the disruption and effects on
other classes.
We had three tables for injection. It took only
20 minutes for one class. At that time, boys went to
[the]library for reading books. So, children did not
miss class, as we planned very well. We got support
from [the] management board and parents of children.
FGD, Teacher, School-based strategy, Can Tho city,
urban
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mobilized meeting rooms, libraries, etc., for vaccination
days. On vaccination days, activities in these locations
were significantly disrupted. Additionally, teachers noted
that the HPV vaccine delivery schedule needs to be co-
ordinated with the examination schedule for students,
“… if the vaccination session falls in with examination
day, then the school needs to change its schedule to not
influence results of the students”. Some participants men-
tioned that doing HPV vaccine introduction in the
school increases the workload of teachers, notably head
teachers and/or school health officers.
On vaccination day, eligible school girls had to be
absent from class for half an hour or an hour, it
affected the training and learning schedule of teacher
and girls, so the school authority had to arrange
another schedule for them in return for this absence.
FGD, Health workers in Hung Loi and An Cu
communes, NinhKieu district, Can Tho city, urban
However, most interviewed teachers considered vac-
cine delivery in schools to cause minimal disruption and
that prevention of cervical cancer was worth the disrup-
tion and inconvenience of school lessons.
Intersectoral collaboration
Collaboration across sectors was a major theme reiter-
ated by most respondents as being critically important
to the success of the HPV vaccinations implemented.
The example of collaboration was set at the national
level and reinforced by provincial and district-level col-
laboration between the health and education sectors, all
of which created a supportive environment for health
and education collaborations at the lowest level of the
communes.
At the provincial level, the collaboration between the
health and education sectors focused more on broader is-
sues, such as policies to facilitate project implementation
at lower levels. The health sector played the key implemen-
tation role, while the education sector provided support.
Health and education sectors cooperated closely and
effectively during the implementation of [the] HPV
vaccine delivery project. Both sectors agreed on the
activity plan and communication content.
SSI, Director, Provincial Center for Health Education
and Communication, Can Tho city, urban
Meetings were held by the two sectors to agree on a
joint document that clearly outlined the roles and respon-
sibilities of each party in implementing HPV vaccinations.At district and commune levels, local authorities were
more directly involved in project activities. Study partici-
pants credited the direction and participation of local au-
thorities for the favorable support received from different
departments and organizations.
It [the People’s Committee] helped to mobilize and
coordinate the participation of different departments
and organizations in the HPV project.
SSI, Director, District Preventive Medicine Center,
Nong Cong district, Thanh Hoa province, rural
The education departments within targeted districts
directly participated in certain activities as members of
project coordination boards at the district level. This
management scheme helped education leaders have a
broad view of the project design and activity plans,
allowing them to offer timely direction to schools in
conducting scheduled activities.
At the commune level, the collaboration involved joint
implementation of project activities. Respondents re-
ported that health centers were the responsible contact,
directing all project activities at communes, with schools
participating in preparation, communication activities,
and vaccination sessions. School activities included: a)
preparing lists of eligible girls; b) organizing parent
meetings at schools; c) conducting communication ses-
sions for students and parents, which included inviting
health officials to speak; d) delivering invitation letters
and reminding girls of the vaccination day; and e) par-
ticipating jointly on vaccination days.
For school-based delivery, schools participated in pre-
paring the location for vaccinations, facilitating the par-
ticipation of eligible girls, and managing girls during and
after vaccination. For health center–based delivery,
schools facilitated the participation of eligible girls by
allowing them to take a day or a session off during vac-
cination day, if it was organized during class time. But
this occurred only three times over the entire school
year, once for each dose, so missed lessons were easily
made up on other days. In some communes, teachers
escorted the girls to receive vaccinations.
Local project implementers reported that the People’s
Committee leaders not only mobilized the participation
of other organizations, but also directly launched the
first dose of the HPV vaccination campaign and actively
supervised and encouraged project implementers dur-
ing those vaccination days. Under the direction of local
authorities, many other organizations, such as cultural
and information departments, Women’s Unions, and
Youth Unions, also participated in project implementa-
tion. Respondents suggested that, like other develop-
ment projects, the participation of local authorities in
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cilitated community acceptability and participation of
the health and education sectors.
Discussion
At the advent of HPV vaccine availability, commentators
and researchers contemplated the difficulties of imple-
mentation, especially for developing countries, because:
a) the vaccine targeted an age group not typical for
immunization programs; b) the disease and HPV virus
as the cause were not well known; c) the dosing schedule
required three shots over six months; and d) the re-
sources needed for sensitization, mobilization, and imple-
mentation could overwhelm the health system [30-33].
Despite these issues, many countries proceeded with
recommendations for vaccination [5] and organized
programs began to be implemented [4], some showing
early signs of success in reaching adolescents as mea-
sured by first-dose uptake and three-dose coverage
[16,34]. However, as Binagwaho and colleagues note,
there was resistance for developing countries to imple-
ment HPV vaccine because international organizations
felt that resources might be shifted from other effective
child health interventions [35].
Formative research in Vietnam prior to the availability
of HPV vaccine also revealed concerns from policy-
makers about the challenges to be overcome [22,24]. Ra-
ther than assuming HPV vaccine delivery was impossible
and doing nothing, clear, rational advice and suggestions
were given for a delivery strategy that could be feasible
[24]. Our study has demonstrated that successful HPV
vaccine implementation using a variety of approaches is
possible in a low-resource setting like Vietnam. Our
findings highlight positive aspects that worked well to
support feasible implementation, as has been found in
other studies. The program’s credibility with communities
is enhanced by visible endorsement by national and local
government officials and key stakeholders [4,7,19,26,36],
and utilization of the existing infrastructure and resources
of the national routine immunization program leveraged
existing competencies and capacities [7,19,24,36]. As was
found in programs implemented in Rwanda, Peru, and
Australia, delineated roles and responsibilities for all
implementing partners and preparing communities in ad-
vance through awareness raising and sensitization were
critical aspects to the feasibility of HPV vaccine delivery
[7,17,19]. Ladner and colleagues, in their review of pilot
programs from Bhutan, Bolivia, Cameroon, Haiti, Lesotho,
and Nepal, also emphasized the importance of informing
communities about HPV vaccination prior to program
implementation [20]. They found effective and intimate
collaboration between the education and health sectors
to be critical, especially for school-based delivery pro-
grams [20]—key learning from both the Peru andAustralia programs, as well [17,19]. Factors for success-
ful delivery were remarkably similar for low-, middle-,
and high-income countries, providing a roadmap for
other countries currently considering how to design
their national HPV vaccination strategy. Encouragingly,
no notable challenges with vaccine storage, transport
and cold chain were found in this study of HPV vaccine
delivery in Vietnam [20].
As with any new program, good planning and prepar-
ation helps to mitigate significant barriers, but some-
times not everything goes according to plan. As with the
successful components of implementation, the negative
experiences and challenges experienced by Vietnam
were similar to those reported by other countries. For
example, generating a list of eligible girls and selecting
those who are eligible for the program based on pre-
defined criteria was difficult in Rwanda and Peru [7,19],
and both Uganda and Tanzania found that school-based
delivery is easier if girls are selected according to their
grade, rather than by their age [25,36]. Tracking girls for
all three doses and coordinating the dosing schedule
with the school calendar have also been noted to be dif-
ficult for others [7,16,19,20]. Most programs have re-
ported an increase in the workload for health workers to
implement HPV vaccinations, but nearly all reported
that this situation was temporary, short-lived, did not
affect routine services significantly, and could be managed
well if careful planning was done [17,19,37]. Binagwaho
and colleagues noted that having six fixed days for each
of the three doses of HPV vaccine facilitated high
coverage, as it was easier to mobilize communities, co-
ordinate activities, and commandeer resources because
everyone was aware of what would happen and when
[7]. We found that this pulsed approach was also used
for HPV vaccine delivery in Vietnam. Studies from Peru
and eight other pilots noted that multiple visits to schools
and continuously following up with girls was challenging
[19,20]. Focusing the vaccinations on three fixed time
points, similar to a pulsed campaign delivery, might re-
duce the overall workload, as such a schedule would bring
predictability for communities, schools, and the health
system, and it would only temporarily stress other services
for just a few days a year. In summary, most of the chal-
lenges for the feasibility of HPV vaccine delivery found in
our study were logistical, commonly found in a diversity
of other HPV vaccination programs, and they were over-
come through additional coordination and planning in
subsequent rounds of vaccinations.
Limitations
The limitations of this qualitative study should be
noted. The methodology and sampling frame, while
rigorous, could still have excluded important perspectives
in understanding the layered dynamics of implementing
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the regularly established health centers. Data collection
occurred shortly after the third dose of vaccine was deliv-
ered, but recall of earlier activities and experiences by
study participants may have introduced unintentional bias.
Because of the complex nature of both the delivery of this
new vaccine and the overall evaluation design, results
from this feasibility study need to be contextualized within
the results of other evaluation components already pub-
lished [25-27].
Conclusions
This study demonstrated that the feasibility of delivering
HPV vaccinations through schools or health centers in
Vietnam was accomplished through: a) close collabor-
ation between education and health sectors at national,
provincial, district, and commune levels; b) a manage-
able project plan; c) assignment of clear roles and re-
sponsibilities among the parties involved; d) close
coordination and supervision during vaccine implemen-
tation; and e) promotion of an overall enabling environ-
ment by engagement with critical community leadership
organizations and health education centers.
Endnote
aTwo of the co-authors (NQN and LTN) were part of
the interviewing team.
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